Fundraising Fox
Amsterdam · Seed–Late Stage · 59 people tracked
Also known as EQT PARTNERS ASIA LIMITED · EQT Partners Japan K.K. · EQT REAL ESTATE, LLC · Life Sciences Partners · LSP · LSP (Life Sciences Partners)
Find your way into EQT Life Sciences
Sign up to see every warm intro you have to EQT Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EQT Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
EQT Life Sciences invests in innovative life sciences companies developing therapeutics, medical devices, diagnostics and healthtech worldwide. It seeks to identify the most promising scientific innovations addressing significant unmet clinical needs, backing inventors, scientists, clinicians and entrepreneurs whose ideas can improve patient outcomes. The firm operates three investment strategies: Life Sciences Funds (LSP 1-7) focused on drug development across all stages; Health Economic Funds targeting later-stage MedTech, digital health and diagnostics; and a Dementia Fund for neurodegenerative disease treatments. Beyond capital, it provides strategic, clinical, operational, financial and commercial guidance, drawing on a specialized team with deep medical and scientific expertise while striving for superior investor returns.
Source: firm website, verified Aug 3, 2026.
Team · 59 people
from the firm's website & public directories
Founder mafia
3 people who came through EQT Life Sciences went on to found or lead other companies.
What they invest in
from 55 of 67 portfolio companiesHealthtech ×36Biotech ×35Medical Devices ×27AI & Machine Learning ×10Deep Tech ×10Digital Health ×7Enterprise Software ×5Consumer ×3
HQs:United States×17Belgium×5Germany×3Netherlands×3Ireland×2Sweden×2
Investments · 67 tracked
founders shown can be your intro pathBy year:2026 · 42025 · 82024 · 92023 · 72022 · 32021 · 42020 · 22019 · 42018 · 22017 · 12014 · 12010 · 148 dated
Datadog is a cloud-based monitoring and security platform that provides observability, analytics, and protection for infrastructure, applications, and data across enterprises.
Cloud ComputingCybersecurityData & InfrastructureDeveloper ToolsNew York, US
Olivier Pomel(Founder)inAlexis Le-Quoc(Co-founder & CTO)inAmit Agarwal(Executive Officer)inAnthony Merlino(Executive Officer)David Obstler(Chief Financial Officer)inAlexis Lê-Quôc(Founder)
Co-investors8-Bit CapitalAmplify PartnersaVentureBantam GroupBoxGroupComcast Ventures+25 more
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)in
Co-investorsAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture CapitalV-Bio Ventures+1 more
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersSambrinvestWallonie EntreprendreEQT
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Robert Friesen(Founder)in
Co-investorsBioGeneration VenturesBOMCurie CapitalKurma PartnersV-Bio Ventures
Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.
Biotech
Fiorella Kotsias(Chief Scientific Officer)inBernard Vanhove(Chief Development Officer)in
BoardMichel Detheux(Chairman)in
Co-investorsFund+JDRF T1D FundBioqube Ventures
ViCentra develops Kaleido, a compact and user-friendly insulin pump system for people with Type 1 diabetes.
Digital HealthHardwareMedical DevicesUtrecht, DE
Tim Oakes(CTO and Co-founder)
Co-investorsInnovation IndustriesInkef
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalGimvSixty Degree CapitalVivo Capital+3 more
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Co-investorsKreos CapitalNewton BiocapitalBlackRockRosetta Capital Ltd.VI PartnersBootstrap Europe+3 more
T-knife Therapeutics is a biopharmaceutical company developing T cell therapies to treat cancer, with an initial focus on solid tumors.
BiotechHealthtechBerlin, DE
Elisa Kieback(Co-founder & Chief Technology Officer)inThomas Blankenstein(Scientific Founder)Thomas Soloway(Chief Executive Officer)Camille Landis(Chief Business Officer / Chief Financial Officer)inPeggy Sotiropoulou(Chief Scientific Officer)in
Co-investorsAndera PartnersVersant VenturesRA CapitalSixty Degree CapitalFidelity Investments
VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.
BiotechHealthtechMedical Devices
Pieter Reitsma(Founder)inJohn Glasspool(Chief Executive Officer)in
Co-investorsBioGeneration VenturesInkefSound BioventuresYsios CapitalEICUNIIQ+2 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)inJosh Mandel-Brehm(Co-Founder)in
Co-investorsDroia VenturesKurma PartnersPureos BioventuresSeroba Life SciencesEurazeoIdinvest Partners+1 more
Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.
BiotechHealthtechPalo Alto, US
Luis Pena(President & Chief Executive Officer)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)
Board seatFelice Verduyn - Van Weegen· per SEC Form D · $115.5M raise · filed Jan 2025
Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalBeiersdorf Innovation FundFemHealth Ventures+4 more
.jpeg){kind=logo}
Lumeon provides an automated care orchestration platform that pulls data from health systems' care processes and existing systems and applies clinical intelligence to coordinate individualized patient care.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechBoston, US
Robbie Hughes(CEO and Founder)in
Board seatRudy Dekeyser· per SEC Form D · $12M raise · filed Aug 2023
Co-investorsEndeavour VisionOptum VenturesTechstarsAmadeus Capital Partners
1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.
AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US
Bernt Øyvind Børnich(CEO)inBernt Børnich(Founder)in
Co-investorsAccess Ventures (New York)AF WPartnersAlliance VCAlliance VentureavraEQT Ventures+14 more
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Chief Platform Officer, Co-founder)inJack O’Meara(Chief Executive Officer, Co-founder)inDave Hardwicke(Director, Head of Business Development, Co-founder)
Co-investorsage1BackedBlueYard CapitalEntrepreneur FirstGlobal Health Investment CorporationIaso Ventures+6 more
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Co-investorsAndera PartnersATEM Capital FundCTI Life Sciences Fund L.P.Kurma PartnersOctalfaSofinnova Partners+4 more
Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersDementia Discovery FundM VenturesNovartis Venture FundPfizer Venture InvestmentsRA Capital+6 more
Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.
BiotechConsumerHealthtechZug, CH
Co-investorsAndera PartnersF-Prime CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersBRV Capital ManagementH.I.G. BioHealth Partners
Biotech
Co-investorsKurma PartnersSofinnova PartnersJohnson & Johnson Innovation – JJDCM VenturesSR One Capital Management
Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.
BiotechDeep TechHealthtechMedical Devices
Co-investorsF-Prime CapitalNovartis Venture FundRiverVest Venture PartnersSanofi Venturesabrdn plc
Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.
FemTechHealthtechMedical Devices
Co-investorsAndera PartnersBorski FundSeroba Life SciencesAtlantic Bridge VenturesEarlybird Venture Capital
BiotechSan Leandro, US
Steve Abella(Chief Medical Officer)inGraeme Currie(Chief Operating Officer)inStephen W. Lau(President, Chief Executive Officer, and Treasurer)inKenneth Schwartz(Executive Officer)inEric Yuen(Executive Officer)inMarten Steen(Director)in
Co-investorsHealthCapInkefSectoral Asset ManagementSofinnova VenturesYsios Capital
Cambridge Vision Technology develops diagnostic hardware and software for detecting Alzheimer's disease and other neurodegenerative conditions through retinal imaging and biomarker analysis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, US
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Co-investorsBioMedPartnerscoparionHadean VenturesInkefFund+Sunstone Capital
Cloudflare provides a global cloud network platform delivering security, performance, and development services through sixty-plus integrated services including SASE, application security, and full-stack development infrastructure.
Cloud ComputingCybersecurityDeveloper ToolsSan Francisco, US
Matthew Prince(Founder)inMichelle Zatlyn(Co-founder and President)inLee Holloway(Founder)Dane Knecht(Chief Technology Officer)inThomas Seifert(Chief Financial Officer)inAlissa Starzak(Chief Legal Officer and Secretary)in
Co-investorsApposite CapitalCapitalGEQT VenturesFlagship PioneeringIcon VenturesIrregular Expressions+18 more
Cyted Health develops diagnostics for earlier and more accurate detection of esophageal disease, including its EndoSign capsule sponge cell collection device and molecular diagnostics, intended for clinicians screening for conditions such as Barrett's Esophagus and esophageal cancer.
BiotechHealthtechMedical Devices
Co-investorsAdvent Life Sciences
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Co-investorsAPERTURE Venture PartnersBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSeroba Life Sciences+1 more
EQT Group is a global private markets firm that invests and builds across private capital, infrastructure, and real estate.
Enterprise Software
Conni Jonsson(Founder and Honorary Chair)in
Co-investorsBCIElmehøj VenturesEQT Ventures
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVBoehringer Ingelheim Venture FundNovalis LifeSciencesOmega FundsPWV
HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.
AI & Machine LearningBiotechHealthtech
BoardBruce Booth(Chairman)in
Co-investorsAtlas VentureB Capital GroupB4 CapitalMRL Ventures FundPivotal Life SciencesSofinnova Partners+2 more
BiotechEast Providence, US
Manny Avila(Executive Officer, Director)inDirk Kuyper(Executive Officer, Director)inRobert Rabiner(Executive Officer)
BoardDaniel Omstead(Director)Fouad Azzam(Director)inRajeev Dadoo(Director)
Co-investorsPappas CapitalSR One Capital Management
ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.
BiotechHealthtech
Daniel Olive(Founder)
Co-investorsAgent CapitalAndera PartnersKurma PartnersPfizer Venture InvestmentsPureos BioventuresAlexandria+4 more
Kaleido offers a modular enterprise platform with pre-integrated products for tokenization, custody, digital assets, middleware, interoperability, and blockchain infrastructure.
Crypto & Web3Data & InfrastructureEnterprise Software
Steve Cerveny(Founder)inSophia Lopez(Founder)in
Co-investorsConsenSys MeshValor Capital GroupFlagship PioneeringInnovation IndustriesInvest-NLMenlo Ventures+1 more
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.
HardwareHealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesClaret Capital PartnersFountain Healthcare PartnersMVM Life Science PartnersSofinnova PartnersEnterprise Ireland+1 more
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+5 more
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.
BiotechHealthtechMedical Devices
Co-investorsBain Capital Life SciencesBioGeneration VenturesFrazier Life SciencesForbion
Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.
AI & Machine LearningHealthtechIoT
Roeland Pelgrims(Founder)inBert De Haes(Founder)Stijn Verrept(Founder)
Co-investors15th RockAngelini VenturesPMVSkystar Capital
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)inVolker Knappertz(Executive Vice President of Research & Development)inMichael Samar(Chief Financial Officer)inRob Lasser(Chief Medical Officer)in
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQTForbion+2 more
Immunotherapy company developing NOUS-209 for the prevention of Lynch syndrome-associated cancers.
Co-investors5AM VenturesAndera PartnersAngelini VenturesCDP Venture CapitalIndaco Venture PartnersM Ventures+6 more
NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development.
FemTechHealthtechMedical DevicesGalway, IE
Barry(CEO & Founder)inMarie Therese(COO & Co-Founder)inPadraig(CTO & Co-Founder)
Co-investorsCatalytic Impact FoundationTMC Venture FundEnterprise Ireland
Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health.
Digital HealthHealthtechMedical DevicesEindhoven, NL
Co-investors15th RockGimvimec.xpandInnovation Industries
PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.
BiotechDeep TechHealthtechMedical DevicesMol, BE
Sven van den berghe(CEO)inChristophe Malice(CBO)inSamy Bertrand(Founder)inYves Sterckx(Director of Finance & Administration)inPhilippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)Sven Van den Berghe(Founder)
Co-investorsKorysKurma PartnersPMV
Payrails provides a modular financial operating system for enterprises that manages payment and financial workflows.
Enterprise SoftwareFintechSaaSBerlin, DE
Emre Talay(Founder)inNicolas Thouzeau(Founder)inOrkhan Abdullayev(Founder)in
Co-investorsAndreessen HorowitzDeBa VenturesEQT VenturesGeneral CatalystHV Capital
.png)
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSeroba Life SciencesSV Health InvestorsEnterprise Ireland
Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.
Deep TechDigital HealthHealthtechMedical Devices
Co-investorsAphelion CapitalInnvotec Ltd.Northern GritstoneSectoral Asset Management
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
HealthtechPlymouth, US
Thomas Westling(Executive Officer, Director)inMartha Shadan(Executive Officer, Director)Randy Nuernberg(Executive Officer)Craig Van Kampen(Executive Officer)
BoardFouad Azzam(Director)inScott Weiner(Director)in
Co-investorsNew Enterprise Associates (NEA)Pappas CapitalPappas Capital
RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease.
BiotechHealthtech
Co-investorsFrazier Life SciencesLifeArc VenturesOxford Science EnterprisesWellington ManagementForbionMonograph Capital Partners+1 more
Sana is an AI lab that develops agentic AI systems to help teams access knowledge, automate repetitive work, and learn.
AI & Machine LearningEnterprise SoftwareFuture of WorkStockholm, SE
Anna Nordell-Westling(Founder)Joel Hellermark(Founder)
Co-investorsAcequia Capital (AceCap)EQT VenturesLeksell Social VenturesMenlo VenturesNew Enterprise Associates (NEA)Workday Ventures
Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAstellas Venture Management LLCF-Prime CapitalFast Track InitiativeJIC Venture Growth InvestmentsKyoto University Innovation Capital
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
Co-investorsAsabys PartnersNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalCriteria Bio Ventures+3 more
The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.
Dominik Schumacher(Founder)in
Co-investorsAndera PartnersAscenta CapitalBayern KapitalBioMedPartnerscoparionFrazier Life Sciences+7 more
Vaderis develops a first-of-its-kind oral therapy for hereditary hemorrhagic telangiectasia (HHT), a rare vascular disease with no existing approved treatments.
BiotechHealthtechMedical Devices
Co-investorsDroia VenturesMedicxiGoldman Sachs
Kaleido, a lightweight modular precision-dosing insulin pump.
Co-investorsInkefInnovation IndustriesForbionInvest-NLROM Utrecht Region
VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data.
AI & Machine LearningData & InfrastructureFintech
Co-investorsAIN VenturesMultiball CapitalDroia VenturesEurazeoKurma PartnersPureos Bioventures
VICO is an online platform for finding verified furnished monthly housing — rooms, studios, and apartments — aimed at students, young professionals, and digital nomads relocating to a new city.
B2B MarketplacesConsumerMarketplacesPropTechTravel & HospitalityMedellín, CO
Manuel FranzinTilman Burfeindin
Co-investors500 GlobalDroia VenturesEurazeoKurma PartnersPureos Bioventures
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.
BiotechDeep TechHealthtechMedical Devices
Eliane Schutte(Chief Executive Officer)in
Co-investorsKurma PartnersVI PartnersYsios CapitalAmadeus Capital PartnersInvest-NL
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Kiadis Pharma N.VActoGeniXHarvest AutomationNeuraviNkarta TherapeuticsProsensaSimplify MedicalVisus TherapeuticsXilis, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 5
2 IPOs · 3 acquisitions · showing 4DatadogNASDAQ: DDOGImcheckacq. by ClementiaNeuraviacq. by Johnson & JohnsonTubulis GmbHacq. by Gilead Sciences
Portfolio news
latest coverage across their companiesVaderis Therapeutics · finsmes.com · Aug 11, 2026
Xeltis · globenewswire.com · Jul 28, 2026
RQ Bio · finsmes.com · Jun 24, 2026
Neurent Medical · finance.yahoo.com · Feb 12, 2026
Kinaset Therapeutics · finsmes.com · Jan 12, 2026
Artios Pharma · eu-startups.com · Nov 17, 2025
Neuros Medical · finsmes.com · Jul 9, 2025
Frequently asked questions
- How many investments has EQT Life Sciences made?
- EQT Life Sciences has 67 tracked investments, 5 of which have exited, including 15 dated in the last 24 months.
- What stage does EQT Life Sciences invest at?
- EQT Life Sciences invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is EQT Life Sciences's typical check size?
- EQT Life Sciences typically writes checks of $11M – $66M.
- What sectors does EQT Life Sciences focus on?
- EQT Life Sciences focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
- Where is EQT Life Sciences located?
- EQT Life Sciences is headquartered in Amsterdam, NL.
- Does EQT Life Sciences lead rounds?
- Yes, EQT Life Sciences leads investment rounds.
- Who does EQT Life Sciences co-invest with?
- EQT Life Sciences most often shares deals with EQT Ventures, 15th Rock, Icon Ventures, among 66 tracked co-investors.
Media · Podcasts & interviews
from their channelEQT Value Creation Day in London 2026
EQT
EQT AB Annual Shareholders' Meeting 2026
EQT
Per Franzen and Jean Eric Salata on CNBC's Squawk Box Asia
EQT
India's Investment Journey with Hari Gopalakrishnan
EQT
How Being an “Outsider” Could Give You an Inside Advantage
EQT
Stop Trying to Be Like Everyone Else, Says Our Founder
EQT
Co-investors · 55
Andera Partners is an asset management firm specializing in private equity that partners with companies and their management to support sustainable growth. It has backed 377 companies over more than 20 years.
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies aligned with Sanofi's mission of advancing human health.
Ysios Capital is a life sciences venture investor that finances innovative biotech companies developing novel therapies for high unmet medical needs, primarily across Europe and the United States.
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
SR One Capital Management is a life sciences venture capital firm that takes a 'back-and-build' approach, providing entrepreneurs with human, intellectual, and financial resources. It emerged from the legacy SR One team formerly part of GSK.
The Novartis Venture Fund invests in innovative life science companies, primarily in biotechnology and biopharmaceuticals, at various stages of development across North America and Europe.
▶43 more co-investors
Polaris PartnersAtlas VentureOrbiMedAmadeus Capital PartnersVersant Ventures5AM VenturesAtlantic Bridge VenturesPfizer Venture InvestmentsPivotal Life SciencesMC Healthcare VenturesAPERTURE Venture PartnersFounder CollectiveCanaan PartnersVenrockUS Venture PartnersEarlybird Venture CapitalOUP (Osage University Partners)AbingworthFrazier Healthcare PartnersVivo CapitalAdvent Life SciencesSamsara BioCapitalPontifax Venture CapitalCatalio Capital ManagementMission BiocapitalBioqube VenturesPappas CapitalSignet Healthcare PartnersPlug and Play VenturesBalderton CapitalCreandumAntlerARCH Venture PartnersXtripe AngelsThird Rock VenturesIterative Instinct CapitalBusiness Growth FundVantagePoint Capital PartnersIllumina VenturesCasdin CapitalTheVentureCityStanley VenturesQima Ventures
Firms observed investing alongside EQT Life Sciences, from public investor directories. Shared companies are the overlap with EQT Life Sciences's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
LYFE Capital is a transpacific healthcare investment firm operating across the U.S. and Asia, investing in biotech, medtech, pharma, and healthcare services companies.
Blackstone is one of the world's largest alternative investment firms, managing over $1.3 trillion across private equity, real estate, credit and insurance, multi-asset investing, infrastructure, and life sciences. Blackstone Life Sciences is the firm's dedicated life sciences investing business.